Here are three quick facts:
1. Zacks’ analysts estimate the company shares will hit between $55 and $80 in the next year.
2. Zacks’ analysts gave Integra LifeSciences an average broker rating of 1.85.
3. Integra LifeSciences Holdings’ headquarters are in Plainsboro, N.J.
More articles on devices:
EOS imaging partners with Spinologics — 5 highlights
Technavio: Global reverse shoulder arthroplasty market to grow — 5 takeaways
National Science Foundation awards SBIR grant to OsteoVantage — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
